PhaseBio Pharmaceuticals: Q1 Earnings Insights

PhaseBio Pharmaceuticals PHAS reported its Q1 earnings results on Monday, May 16, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

PhaseBio Pharmaceuticals beat estimated earnings by 65.15%, reporting an EPS of $-0.23 versus an estimate of $-0.66.

Revenue was up $117.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.31 which was followed by a 5.0% drop in the share price the next day.

Here's a look at PhaseBio Pharmaceuticals's past performance:

To track all earnings releases for PhaseBio Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.